Moreover, if phenoconversion to clinically manifest disease is the key meaningful event, consensus will be needed across ALS and FTD experts on the operational definition of phenoconversion in the context of C9orf72 disease. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.